Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
DKFZ together with Technical University of Denmark (DTU) developed an analogue of Griseofulvin as a compound for cancer treatment, which selectively targets cancer cells only.
Griseofulvin is a natural antibiotic produced by Penicillium griseofulvum as well as other microfungi and is still commonly used in humans for the treatment of dermatomycoses of skin, hair, and nails caused by Microsporum, Trichophyton, and Epidermophyton. Further hit to lead development of the natural compound was achieved by medicinal chemistry with corresponding biological activity tests. Advantages – drug which selectively targets cancer cells only with little effect on normal tissues – possible treatment of several cancer types – analogue of natural compound (griseofulvin, orally available, almost no side effects in humans), thoroughly studied in biological tests
Further Information: PDF
Deutsches Krebsforschungszentrum DKFZ
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
